Results showed that 57.8% of HCC patients exhibited FAK copy number amplification (Fig. S1C), and that FAK expression levels were significantly higher in tumor tissues than in normal liver tissues (Fig. S1D). Here, PTK2 is linked to hepatocellular carcinoma.